NAFLD is the leading cause of chronic liver disease, along with higher risk of diabetes, cardiovascular disease, and cancer, and thus a major public health challenge. NAFLD represents a therapeutic area of as yet unmet clinical lead.
This 4th iteration of the EASL NAFLD Summit promises to bring together all of you engaged in tackling NAFLD, including clinicians, researchers, policy and public health specialists, and industry professionals.
Join us to:
- explore in depth the most relevant developments and challenges
- enjoy a wide breadth of topics from disease mechanisms to biomarkers and models of care
- explore the latest therapeutic developments
- present research and learn from peers
- participate in panel-based discussions on controversial topics
- learn about current and future clinical management in case-based multidisciplinary approaches
- network with key opinion leaders, and more.